Scarica l'app Stockscreener
0.005
17.76%
-0.00108
Precedente Chiudi:
$0.00608
Aprire:
$0.005
Volume 24 ore:
37,026
Relative Volume:
0.71
Capitalizzazione di mercato:
$N/A
Reddito:
$1.67M
Utile/perdita netta:
$-4.29M
Rapporto P/E:
-0.00318
EPS:
-1.5705
Flusso di cassa netto:
$-5.86M
1 W Prestazione:
+6.38%
1M Prestazione:
+85.19%
6M Prestazione:
-26.44%
1 anno Prestazione:
-82.70%
Intervallo 1D:
$0.005
$0.005
Intervallo di 1 settimana:
$0.004
$0.00608
Portata 52W:
$0.0027
$0.0158
Petros Pharmaceuticals Inc Stock (PTPI) Company Profile
Compare PTPI vs TAK, TEVA, HLN, ZTS, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PTPI
Petros Pharmaceuticals Inc
|
0.005 | 0 | 1.67M | -4.29M | -5.86M | -1.5705 |
TAK
Takeda Pharmaceutical Co Adr
|
18.88 | 58.31B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
39.48 | 43.22B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.295 | 40.41B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
71.11 | 30.15B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
496.51 | 21.32B | 3.17B | 1.29B | 1.01B | 27.09 |
Petros Pharmaceuticals Inc Borsa (PTPI) Ultime notizie
Petros Pharmaceuticals Stock Price Forecast. Should You Buy PTPI? - StockInvest.us
India Erectile Dysfunction Drugs Market Outlook, 2033 - grandviewresearch.com
Petros net loss narrows 40.06% to $1.94 million in 1H FY26; SG&A drops 38.2% to $2.02 million - Bitget
Biofrontera Inc. (BFRI) stock price, news, quote and history - Yahoo Finance Singapore
Petros Pharmaceuticals, Inc. Revenue Breakdown – OTC:PTPI - TradingView
Galera Therapeutics, Inc. (GRTXD) Stock Price, News, Quote & History - Yahoo Finance
QTREX Quantum Ltd. (QTEX) stock price, news, quote and history - Yahoo Finance UK
Pasithea Therapeutics Corp. (KTTA) Stock Price, News, Quote & History - Yahoo! Finance Canada
Pasithea Therapeutics Corp. (KTTA) stock price, news, quote and history - Yahoo Finance UK
If You Invested $1,000 in Pharmadrug Inc (LMLLF) - Stock Titan
If You Invested $1,000 in Resonate Blends Inc (KOAN) - Stock Titan
Pliant Therapeutics, Inc. Files Form 8-K with SEC Detailing Company Information and NASDAQ Listing - Minichart
Price to sales forward of Petros Pharmaceuticals, Inc. – OTC:PTPI - TradingView
Enterprise value to EBITDA forward of Petros Pharmaceuticals, Inc. – OTC:PTPI - TradingView
Petros Pharmaceuticals Inc (PTPI) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
INDEXPLUS Trust Series 2003-1 June 2026 Distribution Report: $1.13M Interest Distributed, Principal Balance Unchanged – Minichart - Minichart
Petros Pharmaceuticals Appoints New Chief Accounting Officer - The Globe and Mail
Petros Pharmaceuticals, Inc. Announces Principal Financial Officer Changes, Effective June 18, 2026 - marketscreener.com
Petros Pharmaceuticals, Inc. Announces Executive Changes, Effective June 18, 2026 - marketscreener.com
Petros Pharmaceuticals Inc (PTPI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Petros Pharmaceuticals Inc (PTPI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Petros Pharmaceuticals Inc (PTPI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Petros Pharmaceuticals Inc (PTPI) Institutional Confidence - TradingKey
Petros Pharmaceuticals Inc (PTPI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Petros Pharmaceuticals Inc (PTPI) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Petros Pharmaceuticals Inc (PTPI) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Petros Pharmaceuticals Inc (PTPI) Valuation: PE, PB & Fair Value Analysis - TradingKey
Indonesia Erectile Dysfunction Drugs Market Size & Outlook, 2033 - grandviewresearch.com
Petros Pharmaceuticals Grants Targeted Equity Awards to Leadership - The Globe and Mail
Petros Pharmaceuticals, Inc. 8-K SEC Filing June 5, 2026 – Company Details, Address, and Emerging Growth Status - Minichart
Petros grants restricted shares to Joshua Silverman, Bruce Bernstein, Fady Boctor and Wayne Walker - TradingView
Number of shareholders of Petros Pharmaceuticals, Inc. – OTC:PTPI - TradingView
TradingKey - TradingKey
Petros Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Gilead Sciences Q1 2026 Financial Report: Key Highlights, Financial Statements & Risk Factors - Minichart
Petros Pharma Stock Plunges To Record Low On 1-For-25 Reverse Split, But Retail Optimism Lingers - MSN
Petros Pharmaceuticals Transitions to Healthcare Technology with Proprietary Rx-to-OTC SaaS and SaMD Platform Targeting Self-Care Market 36 - Minichart
Petros Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Petros Pharmaceuticals (PTPI) details tech pivot, default fallout and cash strain - Stock Titan
Petros Pharmaceuticals 2025 10-K: Net income $1.91M; continuing ops loss $(4.50)M - TradingView
Petros Pharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Death Cross: Can Petros Pharmaceuticals Inc expand its profit margins2026 Earnings Surprises & Growth Focused Entry Point Reports - baoquankhu1.vn
Rate Cut: Can Petros Pharmaceuticals Inc expand its profit margins2026 WrapUp & Technical Confirmation Trade Alerts - baoquankhu1.vn
Stock List: Research Stocks from Around the World - GuruFocus
Published on: 2026-04-07 04:40:22 - baoquankhu1.vn
Strategy Inc (STRC) Reports 2026 Bitcoin Holdings, Financial Highlights, and Trading Information on NASDAQ - Minichart
USA Stocks: Research Stocks from USA Stock Market - GuruFocus
Petros Pharmaceuticals Delays Annual 10-K Filing - TipRanks
Petros Pharmaceuticals (NASDAQ: PTPI) notifies SEC of delayed 2025 10-K filing - Stock Titan
Buybacks Report: Can Petros Pharmaceuticals Inc lead its sector in growthMarket Sentiment Summary & Expert Verified Stock Movement Alerts - baoquankhu1.vn
Chipmakers Recap: Can Petros Pharmaceuticals Inc lead its sector in growth2026 Setups & Momentum Based Trading Ideas - baoquankhu1.vn
Petros Pharmaceuticals Inc Azioni (PTPI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.80%
1.25%
Capitalizzazione:
|
Volume (24 ore):